These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5436986)

  • 1. [Current therapeutic possibilities with semi-depot-allergen extracts in the specific treatment of inhalation allergies].
    Wüthrich B; Ott F
    Med Welt; 1970 Mar; 10():400-3. PubMed ID: 5436986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Semi-depot-extracts in the specific desensitization of allergic diseases of the respiratory organs].
    Wüthrich B
    HNO; 1970 Mar; 18(3):67-8. PubMed ID: 5448568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent aspects in the desensitization treatment of inhalation allergies].
    Geissler H
    Verh Dtsch Ges Inn Med; 1968; 74():1280-3. PubMed ID: 5714297
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of respiratory allergies with deposit-injections].
    Dal Bo S
    Folia Allergol (Roma); 1965; 12(3):151-4. PubMed ID: 5878974
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific hyposensitization of respiratory allergies with a new, tetrahydrofuran-treated semi-depot extract: a two-year study on effects and side effects.
    Rudolph R; Staud RD; Baumgarten C; Kunkel G
    Lung; 1978; 155(4):297-308. PubMed ID: 732351
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of oromucosal immunotherapy in respiratory allergy.
    Brown JL; Frew AJ
    Clin Exp Allergy; 2001 Jan; 31(1):8-10. PubMed ID: 11167944
    [No Abstract]   [Full Text] [Related]  

  • 7. [Desensitization in allergic diseases with semi-depot preparations].
    Wüthrich B
    Praxis; 1969 Oct; 58(42):1346-7. PubMed ID: 5396156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of desensitization in the treatment of respiratory allergies].
    Vervloet D; Romanet S; Magnan A
    Rev Mal Respir; 2000 Feb; 17(1 Pt 2):287-92. PubMed ID: 10902142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and its persistence, in children and adults.
    Di Rienzo V
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Practical realization of specific hyposensitization].
    Fuchs E
    Med Klin; 1972 Jul; 67(29):988-90. PubMed ID: 5051383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Specific hyposensitization in allergic diseases (author's transl)].
    Kersten W; Kasperski J; Worth G
    Dtsch Med Wochenschr; 1977 Dec; 102(51):1877-81. PubMed ID: 618363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy and therapeutic control of allergic diseases].
    Fuchs E
    Z Hautkr; 1984 Feb; 59(4):211-29. PubMed ID: 6711077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Wüthrich B; Häfner G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):281-90. PubMed ID: 7367848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical problems in specific hyposensitization].
    Oehling A
    Med Klin; 1972 Jul; 67(29):983-8. PubMed ID: 5051382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specific desensitization or treatment with depot steroids in allergic disorders?].
    Wortmann F
    Ther Umsch; 1969 Dec; 26(12):711-3. PubMed ID: 5386690
    [No Abstract]   [Full Text] [Related]  

  • 18. [New strategies for preventing allergies (interview by Waldtraud Paukstadt)].
    von Mutius E
    MMW Fortschr Med; 2006 May; 148(18):39-40. PubMed ID: 16739265
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities and limits of desensitization].
    Mohorn M; Wenz W
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):524-6. PubMed ID: 7303744
    [No Abstract]   [Full Text] [Related]  

  • 20. LAIS - Posological schedules.
    Bruno M
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.